+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
Sorbitol Market Report and Forecast 2023-2028 - Product Thumbnail Image

Sorbitol Market Report and Forecast 2023-2028

  • Report
  • September 2023
  • 169 Pages
  • Global
From
Asia Pacific Sorbitol Market Report and Forecast 2024-2032 - Product Thumbnail Image

Asia Pacific Sorbitol Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 160 Pages
  • Asia Pacific
From
Europe Middle East and Africa Sorbitol Market Report and Forecast 2024-2032 - Product Thumbnail Image

Europe Middle East and Africa Sorbitol Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 158 Pages
  • Europe, Africa, Middle East Europe, Africa, Middle East
From
Latin America Sorbitol Market Report and Forecast 2024-2032 - Product Thumbnail Image

Latin America Sorbitol Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 152 Pages
  • Latin America
From
North America Sorbitol Market Report and Forecast 2024-2032 - Product Thumbnail Image

North America Sorbitol Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 155 Pages
  • North America
From
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more